Cosmetic Surgery and Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Cosmetic Surgery and Services Market is segmented by Treatment Type (Surgical and Non-surgical) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

Market Snapshot

Cosmetic surgery and services market Overview
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The cosmetic surgery and services market is projected to register a CAGR of 5.5% during the forecast period (2022-2027).

According to a research article by Dana E Bregman et al., published in the Aesthetic Surgery Journal July 2020, in the United States, the total surgeons' fees derived from both surgical and minimally invasive procedures in 2018 was approximately USD 5 billion. The current pandemic had resulted in an approximately 20% decrease in collected fees, which is expected to show a negative impact on the market studied in 2020. As the COVID-19 pandemic has grown in magnitude, the safety of ablative resurfacing lasers, micro-needling, and dermatological surgery procedures has become questionable. Additionally, a slowing economy and reduced discretionary spending discourage customers from undergoing expensive cosmetic treatments, imposing a practical restriction.

The key factors propelling the growth of this market are technological advancements in devices, growing demand for minimally invasive and non-invasive procedures, and growing awareness regarding cosmetic surgery. According to the American Society of Plastic Surgeons, in 2020, 2.3 million cosmetic surgical procedures and 13.2 million cosmetic minimally invasive procedures, 6.8 million reconstructive procedures were performed in the United States, with a 3% increase in the number of procedures over 2019. Thus, the growing popularity of aesthetic treatment for facial enhancement is the key driver of this market.

The demand for cosmetic surgeries and minimally invasive procedures, such as botulinum toxin and facial filler injections, has increased dramatically over the past decade. It has been observed since the past few years that US citizens are spending more money on cosmetic surgeries. Market players are frequently launching technologically advanced products, which is likely to drive the segment growth during the forecast period. For instance, in August 2020 Revance has launched the RHA (resilient hyaluronic acid) collection of fillers. The resilient hyaluronic acid fillers are designed to adapt to facial dynamics and represent the first step in line of products for aesthetic practices. Owing to these aforementioned factors, along with technological advancements in devices and growing awareness regarding cosmetic surgery, the cosmetic surgery and services market is expected to grow rapidly over the forecast period.

Scope of the Report

Cosmetic plastic surgery includes surgical and non-surgical procedures that enhance and reshape structures of the body to improve appearance and confidence. Since it is elective, cosmetic surgery is usually not covered by health insurance. The Cosmetic Surgery and Services Market is segmented by Treatment Type (Surgical and Non-surgical) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Treatment Type
By Surgical
Breast Augmentation
Liposuction
Tummy Tuck
Eyelid Surgery
Breast Lift
By Non-surgical
Botulinum toxin
Dermal Fillers
Laser Hair Removal
Photo-rejuvenation
Microdermabrasion
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Botulinum Toxin Segment is Expected to Witness the Fastest Growth in the Market

Botulinum toxin is a highly poisonous, naturally occurring substance, but has wide applications. The most common use of this toxin is in the treatment of painful muscle spasms and cosmetic treatment. Botox and Dysport are the commercial names of the botulinum toxin. In 1950, the researchers found that the minute use of this toxin helps in controlling muscle movement. Gradually, they understood that this substance is also beneficial in cosmetic treatments.

According to the American Society of Plastic Surgeons in 2020, there were 13,281,235 cosmetic minimally invasive procedures that were performed in the United States, out of which 4,401,536 were botulinum toxin procedures, and it was the number one non-surgical procedure found in 2020.

There is also increased competition in the United States by several launches for instance, in July 2021, Allergan has received the United States Food and Drug Administration (FDA) approval of a label expansion of BOTOX to include eight new muscles for the treatment of upper limb spasticity in adults. The new muscles for treatment include additional muscles of the elbow and forearm (brachialis, brachioradialis, pronator teres, and pronator quadratus), and others. The study from the American Society of Plastic Surgeons found that Botox injections became the most popular non-invasive cosmetic procedure in 2020, with 4.4 million procedures performed in 2020. Hence, the use of botulinum toxins in aesthetic medicine has increased, remarkably. Botox injections are used for the treatment of frown lines, crow's feet, and horizontal forehead lines, which are the cosmetic indications approved by the United States Food and Drug Administration. It offers predictable results with few adverse effects and is associated with high patient satisfaction with the rising applications of the substance, the segment is expected to experience fast growth across various regions of the world.

Cosmetic surgery and services market Key Trends

North America is Expected to Dominate the Market Over the Forecast Period

North America dominates the cosmetic surgery and services market, owing to the rising population pool focusing on external aesthetics and the improvements that are being done in cosmetic procedures. According to the American Society of Plastic Surgeons (ASPS), in 2020, 15.5 million cosmetic procedures were performed in the United States, out of which, 13.2 million were minimally invasive.

As per the International Society of Aesthetic Plastic Surgery, there were 456,489 surgical procedures and 404,229 nonsurgical procedures done in Mexico in 2020, which has been increased from 437,880 in 2018. Hyaluronic acid procedures were the second-most common injectable procedure, accounting for a total of 123,707 procedures in 2020.

Currently, people in this region are spending more money on cosmetics and are eager to adopt novel cosmetic treatments this factor is giving rise to many market development strategies. For instance, In September 2021, Galderma, RESTYLANE portfolio continues to grow and expand. RESTYLANE EYELIGHT launched as a targeted treatment solution to combat under-eye shadows. In February 2021, the FDA approved RESTYLANE DEFYNE for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21. Moreover, in the future new product approvals and launches are expected to hit the market, therefore the studied market in this region is expected to witness rapid growth.

Cosmetic surgery and services market Growth by Region

Competitive Landscape

The cosmetic surgery and services market is consolidated. Certain key players having the major market share include Abbvie, Bausch Health Companies Inc., Merz Pharma GmbH & Co. KGaA, Galderma SA, and Johnson & Johnson. With the help of product innovation, few small-sized companies are also penetrating the market and are holding a substantial share.

Recent Development

In May 2021, GC Aesthetics, Inc, announced the launch of its next generation of breast implants, PERLE. PERL is a highly innovative line of smooth breast implants that features a proprietary surface technology , GCA's industry-leading gel technology, and an enhanced version of the safety features that have underpinned GCA's long-term excellent safety record.

In February 2021, Galderma announced that the U.S. Food and Drug Administration (FDA) has approved Restylane Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Technological Advancements in Devices

      2. 4.2.2 Growing Demand for Minimally Invasive and Non-invasive Procedures

      3. 4.2.3 Growing Awareness Regarding Cosmetic Surgery

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Policies

      2. 4.3.2 Side Effects Associated with Cosmetic Treatments

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Treatment Type

      1. 5.1.1 By Surgical

        1. 5.1.1.1 Breast Augmentation

        2. 5.1.1.2 Liposuction

        3. 5.1.1.3 Tummy Tuck

        4. 5.1.1.4 Eyelid Surgery

        5. 5.1.1.5 Breast Lift

      2. 5.1.2 By Non-surgical

        1. 5.1.2.1 Botulinum toxin

        2. 5.1.2.2 Dermal Fillers

        3. 5.1.2.3 Laser Hair Removal

        4. 5.1.2.4 Photo-rejuvenation

        5. 5.1.2.5 Microdermabrasion

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc.

      2. 6.1.2 Bausch Health Companies Inc.

      3. 6.1.3 Cynosure Technologies

      4. 6.1.4 Galderma SA

      5. 6.1.5 Laboratories Vivacy SAS

      6. 6.1.6 Merz Pharma GmbH & Co. KGaA

      7. 6.1.7 Sinclair Pharma PLC

      8. 6.1.8 Syneron

      9. 6.1.9 Teoxane Laboratories

      10. 6.1.10 Vital Esthetique

      11. 6.1.11 Johnson and Johnson

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Cosmetic Surgery and Services Market market is studied from 2019 - 2027.

The Global Cosmetic Surgery and Services Market is growing at a CAGR of 5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Bausch Health Companies Inc., Merz Pharma, Johnson and Johnson, AbbVie Inc., Galderma SA are the major companies operating in Global Cosmetic Surgery and Services Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!